Generalized Likelihood Ratios for Designing Dose Optimization Studies of Targeted Therapies
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Generalized Likelihood Ratios for Designing Dose Optimization Studies of Targeted Therapies
Authors
Keywords
-
Journal
Statistics in Biopharmaceutical Research
Volume -, Issue -, Pages 1-17
Publisher
Informa UK Limited
Online
2023-10-05
DOI
10.1080/19466315.2023.2267494
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bayesian adaptive model selection design for optimal biological dose finding in phase I/II clinical trials
- (2021) Ruitao Lin et al. BIOSTATISTICS
- The Drug-Dosing Conundrum in Oncology — When Less Is More
- (2021) Mirat Shah et al. NEW ENGLAND JOURNAL OF MEDICINE
- The i3+3 design for phase I clinical trials
- (2019) Meizi Liu et al. Journal of Biopharmaceutical Statistics
- BOIN-ET: Bayesian optimal interval design for dose finding based on both efficacy and toxicity outcomes
- (2018) Kentaro Takeda et al. PHARMACEUTICAL STATISTICS
- STEIN: A simple toxicity and efficacy interval design for seamless phase I/II clinical trials
- (2017) Ruitao Lin et al. STATISTICS IN MEDICINE
- Toxicity and Efficacy Probability Interval Design for Phase I Adoptive Cell Therapy Dose-Finding Clinical Trials
- (2016) Daniel H. Li et al. CLINICAL CANCER RESEARCH
- An adaptive dose-finding method using a change-point model for molecularly targeted agents in phase I trials
- (2016) Hiroyuki Sato et al. STATISTICS IN MEDICINE
- Adaptive designs for identifying optimal biological dose for molecularly targeted agents
- (2014) Yong Zang et al. Clinical Trials
- Seamless Phase I/II Adaptive Design for Oncology Trials of Molecularly Targeted Agents
- (2014) Nolan A. Wages et al. Journal of Biopharmaceutical Statistics
- Bayesian optimal interval designs for phase I clinical trials
- (2014) Suyu Liu et al. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS
- Early phase clinical trials to identify optimal dosing and safety
- (2014) Natalie Cook et al. Molecular Oncology
- An adaptive dose-finding approach for correlated bivariate binary and continuous outcomes in phase I oncology trials
- (2011) Akihiro Hirakawa STATISTICS IN MEDICINE
- A modified toxicity probability interval method for dose-finding trials
- (2010) Yuan Ji et al. Clinical Trials
- Toxicity equivalence range design (TEQR): A practical Phase I design
- (2010) M. Suzette Blanchard et al. Contemporary Clinical Trials
- Two-stage design for dose-finding that accounts for both efficacy and safety
- (2008) Vladimir Dragalin et al. STATISTICS IN MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started